Identification of Novel Non-nucleoside Reverse Transcriptase Inhibitors Using Fragment-based Lead Generation

Author： Ramajayam R. Giridhar Rajani Yadav M. De Clercq Erick Pannecouque Christophe Prajapati Dhaval

ISSN： 1054-2523

Source： Medicinal Chemistry Research, Vol.14, Iss.8-9, 2005-12, pp. : 475-487

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update on rilpivirine: A new potent non-nucleoside reverse transcriptase inhibitor (NNRTI) of HIV replication

By Zaharatos Gerasimos J.

Annals of Medicine, Vol. 45, Iss. 3, 2013-05 ,pp. : 236-241

Informa Healthcare

Access to resources Recommend Favorite

JTK-853, a Novel Non-Nucleoside Hepatitis C Virus Polymerase Inhibitor, Demonstrates a High Genetic Barrier to Resistance in vitro

Intervirology, Vol. 56, Iss. 5, 2013-07 ,pp. : 302-309

Karger

Access to resources Recommend Favorite

A Novel Real-Time Multiplex Reverse Transcriptase-Polymerase Chain Reaction for the Detection of HIV-1 RNA by Using Dual-Specific Armored RNA as Internal Control

Intervirology, Vol. 51, Iss. 1, 2008-03 ,pp. : 42-49

Karger

Access to resources Recommend Favorite

Identification of Novel Human HDAC8 Inhibitors by Pharmacophore‐based Virtual Screening and Density Functional Theory Approaches

BULLETIN OF THE KOREAN CHEMICAL SOCIETY (ELECTRONIC), Vol. 39, Iss. 2, 2018-02 ,pp. : 197-206

John Wiley & Sons Inc

Access to resources Recommend Favorite

In silico screening for identification of novel HIV-1 integrase inhibitors using QSAR and docking methodologies

By Gupta Pawan Garg Prabha Roy Nilanjan

Medicinal Chemistry Research, Vol. 22, Iss. 10, 2013-10 ,pp. : 5014-5028

Springer Publishing Company

Access to resources Recommend Favorite